New Centers for Disease Control and Prevention's guidelines on HIV counseling and testing for the general population and pregnant women

Journal of Acquired Immune Deficiency Syndromes

Volumn 32, Issue 2, 2003, Pages 182-191

  Phillips, Kathryn A ^a,d   Bayer, Ronald ^c   Chen, James L ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

CDC counseling and testing guidelines; HIV counseling and testing; Perinatal counseling and testing guidelines

Indexed keywords

ARTICLE; COST EFFECTIVENESS ANALYSIS; COUNSELING; ETHICS; FEMALE; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEALTH CENTER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFECTION RISK; INFORMED CONSENT; NONHUMAN; PATIENT ATTITUDE; POPULATION RESEARCH; PRACTICE GUIDELINE; PREGNANCY; PRIORITY JOURNAL; UNITED STATES;

EID: 0037320003     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200302010-00010     Document Type: Article

References (56)

1. CDC. Revised guidelines for HIV counseling, testing, and referral (and) revised recommendations for HIV screening of pregnant women. MMWR Morb Mortal Wkly Rep 2001;50(RR-19):1-85.
2. Francis D. Toward a comprehensive HIV prevention program for the CDC and the nation. JAMA 1992;268:1444-7.
3. Rhame F, Maki D. The case for wider use of testing for HIV infection. N Engl J Med 1989;321:1248-54.
4. Angell M. A dual approach to the AIDS epidemic. N Engl J Med 1991;324:1498-500.
5. Levi J. Rethinking HIV counseling and testing. AIDS & Public Policy Journal 1996;11:164-8.
6. Institute of Medicine. Reducing the odds-preventing perinatal transmission of HIV in the United States. Washington, DC: National Academy Press, 1999.
7. CDC. HIV counseling, testing, and referral standards and guidelines. Atlanta, GA: Centers for Disease Control and Prevention, 1994.
8. Phillips KA, Flatt SJ, Morrison KR, et al. Potential use of home HIV testing. N Engl J Med 1995;332:1308-10.
9. Kassler W. Advances in HIV testing technology and their potential impact on prevention. AIDS Educ Prev 1997;9(suppl B):27-40.
10. Merson MH, Feldman EA, Bayer R, et al. Rapid self-testing for HIV infection. Lancet 1997;349:352-3.
11. CDC. HIV prevention strategic plan through 2005. Atlanta, GA: Centers for Disease Control and Prevention, 2001.
12. Sweeney P, Fleming P, Ward J, et al. A minimum estimate of HIV-infected persons who have been tested in the US. Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, 1997.
13. Bozzette S, Berry S, Duan N, et al. The care of HIV-infected adults in the United States. HIV costs and services utilization study consortium. N Engl J Med 1998;339:1897-904.
14. Bindman A, Osmond D, Hecht F, et al. Multistate evaluation of anonymous HIV testing and access to medical care. JAMA 1998;280:1416-20.
15. Shapiro M, Morton S, McCaffrey D, et al. Variations in the care of HIV-infected adults in the United States: results from the HIV cost and services utilization study. JAMA 1999;281:2305-15.
16. Weinhardt L, Carey M, Johnson B, et al. Effects of HIV counseling and testing on sexual risk behavior: a meta-analytic review of published research, 1985-1997. Am J Public Health 1999;89:1397-405.
17. Wolitski R, MacGowan R, Higgins D, et al. The effects of HIV counseling and testing on risk-related practices and help-seeking behavior. AIDS Educ Prev 1997;9(suppl 3):52-67.
18. Burris S. Driving the epidemic underground? A new look at law and the social risk of HIV testing. AIDS & Public Policy Journal 1997:66-78.
19. Irwin K, Valdiserri R, Holmberg S. The acceptability of voluntary HIV antibody testing in the United States: a decade of lessons learned. AIDS 1996;10:1707-17.
20. Lee J, Mitchell B, Nolt B, et al. Targeted opt-in versus routine opt-out HIV testing in an STD clinic. HIV Prevention Conference, Atlanta, GA, August 29-September 1, 1999.
21. Freedberg K, Scharfstein J, Seage G, et al. The cost-effectiveness of preventive AIDS-related opportunistic infections. JAMA 1998;279:130-6.
22. Anderson J, Brackbill R, Wilson R. Diagnostic HIV antibody testing in the United States: the role of private providers and public programs. AIDS 1996;10:342-3.
23. CDC. HIV counseling and testing - United States, 1993. MMWR Morb Mortal Wkly Rep 1995;44:169-74.
24. Wenrich M, Carline J, Curtis J, et al. Patient report of HIV risk screening by primary care physicians. Am J Prev Med 1996;12:116-22.
25. Gerbert B, Bronstone A, Pantilat S, et al. Development and testing of an HIV-risk screening instrument for use in health care settings. Am J Prev Med 1998;15:103-13.
26. Chen Z, Branson B, Ballenger A, et al. Risk assessment to improve targeting of HIV counseling and testing services for STD clinic patients. Sex Transm Dis 1998;25:539-43.
27. Kass N. A change in approach to prenatal HIV screening. Am J Public Health 2000;90:1026-7.
28. Loft J, Marder W, Bresolin L, et al. HIV prevention practices of primary-care physicians - United States, 1992. MMWR Morb Mortal Wkly Rep 1994;42:988-92.
29. Gerbert B, Bronstone A, Pantilat S, et al. When asked, patients tell: disclosure of sensitive health-risk behaviors. Med Care 1999;37:104-11.
30. Gerbert B, Bleecker T, Maguire B, et al. Physicians and AIDS: sexual risk assessment of patients and willingness to treat HIV-infected patients. J Gen Intern Med 1992;7:657-64.
31. Gerbert B, Bleeker T, Bernzweig J. Is anybody talking to physicians about acquired immunodeficiency syndrome and sex? A national survey of patients. Arch Fam Med 1993;2:45-51.
32. Phillips KA, Morrison K, Sonnad S, et al. HIV counseling and testing of pregnant women and women of childbearing age by primary care providers: self-reported beliefs and practices. J Acquir Immune Defic Syndr Hum Retrovirol 1997;14:174-8.
33. CDC. Draft: revised guidelines for HIV counseling, testing and referral, October, 17, 2000. [Federal Register: October 31, 2000; vol 65, no 211, pages 65241-65242]. Atlanta, GA: Centers for Disease Control and Prevention, 2000.
34. CDC. Revised US Public Health Service recommendations for human immunodeficiency virus screening of pregnant women, draft 12.0, October 20, 2000 [Federal Register: October 31, 2000; vol 65, no 211, pages 65242-65243]. Atlanta, GA: Centers for Disease Control and Prevention, 2000.
35. Bayer R. Public health policy and the AIDS epidemic: an end to HIV exceptionalism? N Engl J Med 1991;324:1500-4.
36. Bayer R. Clinical progress and the future of HIV exceptionalism. Arch Intern Med 1999;159:1042-8.
37. CDC. Annual report from HIV counseling and testing data system. Atlanta, GA: Centers for Disease Control and Prevention, 1996.
38. National Center for Health Statistics. Public use file documentation, national health interview survey of AIDS knowledge and attitudes, 1993. Hyattsville, MD: National Center for Health Statistics, 1994.
39. Jannsen R, St. Louis M, Satten G, et al. HIV infection among patients in U.S. acute care hospitals. Strategies for the counseling and testing of hospital patients. N Engl J Med 1992;327:445-52.
40. Kamb M, Fishbein M, Douglas J, et al. Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases: a randomized controlled trial. JAMA 1998; 280:1161-7.
41. The National Institute of Mental Health (NIMH) Multisite HIV Prevention Trial Group. The NIMH multisite HIV prevention trial: reducing HIV sexual risk behavior. Science 1998;280:1889-94.
42. Shain R, Piper J, Newton E, et al. A randomized, controlled trial of a behavioral intervention to prevent sexually transmitted disease among minority women. N Engl J Med 1999;340:93-100.
43. Hamm R, Donnell H, Wilson E, et al. Prevention of perinatal HIV transmission: beliefs and practices of Missouri prenatal providers. Missouri Epidemiologist 1996 (March/April).
44. Schluter W, Judson F, Baro'n A, et al. Usefulness of human immunodeficiency virus post-test counseling by telephone for low-risk clients of an urban sexually transmitted diseases clinic. Sex Transm Dis 1996;23:190-7.
45. Anonymous. NASTAD warns CT guidelines will require more funding. STD Advisor 2001;4:6.
46. Skolnik H, Phillips KA, Binson D, et al. Deciding where and how to be tested for HIV: what matters most? JAIDS 2001;27:292-300.
47. Sonnad S. Cost-effectiveness analysis of the new CDC guidelines for HIV counseling and testing [abstract]. Society for medical Decision Making Annual Conference, Baltimore, MD; October 21, 2002.
48. Phillips KA, Fernyak S. The cost-effectiveness of expanded HIV counseling and testing in primary care settings: a first look. AIDS 2000;14:2159-69.
49. Holtgrave D, Valdiserri R, Gerber A, et al. Human immunodeficiency virus counseling, testing, referral, and partner notification services. Arch Intern Med 1993;143:1225-30.
50. Farnham P. Economic evaluation of HIV counseling and testing programs. In: Holtgrave D, ed. Handbook of economic evaluation of HIV prevention programs. New York: Plenum Press, 1998: 63-80.
51. Owens DK, Nease RF Jr, Harris RA. Cost-effectiveness of HIV screening in acute care settings. Arch Intern Med 1996;156:394-404.
52. Chen J, Phillips KA, Kanouse D, et al. Fertility desires and intentions of HIV-positive men and women. Fam Plann Perspect 2001; 33:144-52.
53. Brandeau M, Owens D, Sox C, et al. Screening women of child-bearing age for human immunodeficiency virus: a cost-benefit analysis. Arch Intern Med 1992;152:2229-37.
54. Lindegren M, Byers R, Thomas P, et al. Trend in perinatal transmission of HIV/AIDS in the United States. JAMA 1999;282:531-8.
55. Phillips KA, Branson B, Fernyak S, et al. The home collection HIV test: past, present, and future [a background paper prepared for the Kaiser Family Foundation Forum on "Understanding the Impact of New Treatments on HIV Testing," January 28-30, 1998]. San Francisco, CA: University of California, San Francisco, 1998.
56. Phillips KA, Morin S, Coates T, et al. Home sample collection for HIV testing [letter]. JAMA 2000;283:198-9.